Ovarian Cancer Australia, together with stakeholders, has launched a National Action Plan for Ovarian Cancer Research setting out urgent priorities for the way in which Australia tackles ovarian cancer research, in order to make a significant change in the number of women dying from the disease.

This groundbreaking Plan is aimed at providing a strategic framework for transparent and accountable investment in ovarian cancer research to ensure available funds are used to optimal effect and act as a catalyst to drive further, much needed investment.

This is the first time a national plan has been developed for ovarian cancer and for the first time provides a priority-driven focus for investment, unifying the efforts and providing a blueprint for researchers and funders from around Australia. It also includes a Charter setting out principles for ovarian cancer research excellence and calls for researchers to align with these.

The Plan has been developed in consultation with a wide range of stakeholders in the ovarian cancer field, including women living with the disease, and provides a roadmap setting out research priorities across a number of areas, including biology and origin, prevention, treatment, detection and control. It outlines strategic activities for funding, as well as conducting, supporting and evaluating research. In particular the Plan highlights that the latest research shows that we now know that ovarian cancer is not just one disease but a range of diseases with different cellular appearances, different molecular characteristics, and different trajectories. This new knowledge has not yet translated into new treatments or improved outcomes: the Plan identifies the critical pathways towards achieving this.

As part of the launch of the National Action Plan, Ovarian Cancer Australia also announced a $1 million funding contribution to support the priorities identified in the Plan which includes a $900,000 funding partnership between Ovarian Cancer Australia and the Peter MacCallum Cancer Centre.

For more information about this significant milestone in national ovarian cancer research, click on the following links: